Allianz Asset Management
ROIV icon

Allianz Asset Management’s Roivant Sciences ROIV Stock Holding History

Allianz Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.92M Sell
69,253
-16,713
-19% -$429K ﹤0.01% 1568
2025
Q4 		$1.87M Buy
85,966
+68,742
+399% +$1.36M ﹤0.01% 1569
2025
Q3 		$261K Buy
+17,224
New +$213K ﹤0.01% 1930
2024
Q2 		– Sell
-17,900
Closed -$189K – 2235
2024
Q1 		$189K Sell
17,900
-48,200
-73% -$520K ﹤0.01% 1854
2023
Q4 		$742K Hold
66,100
– – ﹤0.01% 1724
2023
Q3 		$772K Buy
66,100
+46,300
+234% +$523K ﹤0.01% 1789
2023
Q2 		$200 Hold
19,800
– – ﹤0.01% 2118
2023
Q1 		$146K Buy
+19,800
New +$163K ﹤0.01% 2053

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Allianz Asset Management's ROIV Position: Q1 2026 in Review

Allianz Asset Management reduced its Roivant Sciences (ROIV) stake by 19% in Q1 2026, selling an estimated $429K and leaving 69,253 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1568.

Allianz Asset Management first reported a position in ROIV in Q1 2023 and has held it in 8 quarters since. 440 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Allianz Asset Management held 69,253 shares of Roivant Sciences worth $1.92M as of Q1 2026.
  • Allianz Asset Management sold 16,713 Roivant Sciences shares in Q1 2026, an estimated $429K.
  • Roivant Sciences made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1568 holding.
  • Allianz Asset Management first reported a position in Roivant Sciences in Q1 2023 and has held it in 8 quarters since.
  • 440 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.